注册并分享邀请链接,可获得视频播放与邀请奖励。

Sally Pipes
@sallypipes
President, CEO, Thomas W. Smith Fellow in Health Care Policy @PacificResearch. Author: The World's Medicine Chest
加入 September 2009
3.9K 正在关注    8.6K 粉丝
Generics and biosimilars already fill nearly 90% of U.S. prescriptions. If lawmakers want to lower drug costs, they should start with PBMs and other middlemen whose incentives often steer patients away from cheaper alternatives.
显示更多
Despite the savings greater biosimilar competition can deliver, Big Pharma continues to game the system to block more affordable alternatives from reaching patients. Lawmakers should build on recent bipartisan work to advance bipartisan, market-based solutions. More from @Axios:
显示更多